CENTRE HOSPITALIER DE PAU
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1520-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
14
Active:1
Completed:6
Trial Phases
4 Phases
Phase 1:1
Phase 2:1
Phase 4:3
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Not Applicable
5 (50.0%)Phase 4
3 (30.0%)Phase 1
1 (10.0%)Phase 2
1 (10.0%)Determinants of Malignant Hypertension Onset and Related Target Organ Damages: the HAMA Biobank
Not yet recruiting
- Conditions
- Malignant Hypertension
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Centre Hospitalier de PAU
- Target Recruit Count
- 1000
- Registration Number
- NCT06629363
Effect of Protein Supplementation on Craving in Subjects Hospitalised for Addiction Treatment
Not Applicable
Recruiting
- Conditions
- Addiction
- First Posted Date
- 2024-06-14
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Centre Hospitalier de PAU
- Target Recruit Count
- 30
- Registration Number
- NCT06459609
- Locations
- 🇫🇷
CH de Pau, Pau, France
Evaluation of Hypnosis Practice During a Semi-invasive and Painful Medical Examination in Neurology: the Electromyogram
Not Applicable
Completed
- Conditions
- Patients Requiring Electromyogram
- First Posted Date
- 2024-01-05
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Centre Hospitalier de PAU
- Target Recruit Count
- 100
- Registration Number
- NCT06193785
- Locations
- 🇫🇷
CH de Pau, Pau, France
🇫🇷KRIM Elsa, Pau, France
Interrupters of VAscular daMAge in Malignant Hypertension
Completed
- Conditions
- Malignant Hypertension
- Interventions
- Biological: analyse of angiogenic, vasoactive and VEGF systems
- First Posted Date
- 2021-08-05
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Centre Hospitalier de PAU
- Target Recruit Count
- 45
- Registration Number
- NCT04991077
- Locations
- 🇫🇷
Hôpital Avicenne, Bobigny, France
🇫🇷CHU de Bordeaux, Bordeaux, France
🇫🇷Hôpital Bichat, Paris, France
Feasibility of Immunotherapy Plus Chemotherapy Administration to Patients With Bronchial Cancer in a Hospital-at- Home Setting
Completed
- Conditions
- Bronchial Cancer
- First Posted Date
- 2021-03-17
- Last Posted Date
- 2024-02-26
- Lead Sponsor
- Centre Hospitalier de PAU
- Target Recruit Count
- 10
- Registration Number
- NCT04802902
- Locations
- 🇫🇷
Centre hospitalier de pau, Pau, Aquitaine, France
- Prev
- 1
- 2
- 3
- Next
News
No news found